Central role of glutamate metabolism in the maintenance of nitrogen homeostasis in normal and hyperammonemic brain

Biomolecules

Volumn 6, Issue 2, 2016, Pages

  Cooper, Arthur J L ^a   Jeitner, Thomas M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Amino acids; Ammonia; Aspartate; Aspartate aminotransferase; Glutamate; Glutamate dehydrogenase; Glutaminase; Glutamine; Glutamine synthetase; ketoglutarate

Indexed keywords

2 OXOGLUTARIC ACID; 4 AMINOBUTYRIC ACID; 5 OXOPROLINASE; AMINOTRANSFERASE; CARBON DIOXIDE; EXCITATORY AMINO ACID TRANSPORTER; GAMMA GLUTAMYLCYSTEINE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; NITROGEN; GLUTAMINASE;

ACUTE BRAIN DISEASE; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CEREBROSPINAL FLUID ANALYSIS; CITRIC ACID CYCLE; ENERGY METABOLISM; HOMEOSTASIS AND REGULATION; HUMAN; HYDROLYSIS; HYPERAMMONEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; BRAIN; METABOLISM;

BLOOD-BRAIN BARRIER; BRAIN; GLUTAMIC ACID; GLUTAMINASE; HUMANS; HYPERAMMONEMIA; NITROGEN; TRANSAMINASES;

EID: 85012045784     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom6020016     Document Type: Review

References (200)

1. Lajtha, A.B.; Maker, H.S.; Clarke, D.D. Chapter 17. Metabolism and transport of carbohydrates and amino acids. In Basic Neurochemistry, 3rd ed.; Siegel, D.J., Albers, R.W., Agranoff, B.W., Katzman, R., Eds.; Little, Brown and Company: Boston, MA, USA, 1981; pp. 329-353.
2. Huxtable, R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 1989, 32, 471-533. [CrossRef]
3. Ripps, H.; Shen,W. Review: Taurine: A "very essential" amino acid. Mol. Vis. 2012, 18, 2673-2686. [PubMed]
4. Albrecht, J.; Schousboe, A. Taurine interaction with neurotransmitter receptors in the CNS: An update. Neurochem. Res. 2005, 30, 1615-1621. [CrossRef] [PubMed]
5. Dringen, R.; Brandmann, M.; Hohnholt, M.C.; Blumrich, E.M. Glutathione-Dependent Detoxification Processes in Astrocytes. Neurochem. Res. 2015, 40, 2570-2582. [CrossRef] [PubMed]
6. Naini, A.B.; Vontzalidou, E.; Côté, L.J. Isocratic HPLC assay with electrochemical detection of free-aminobutyric acid in cerebrospinal fluid. Clin. Chem. 1993, 39, 247-250. [PubMed]
7. Nicholls, D.G.; Sihra, T.S. Synaptosomes possess an exocytotic pool of glutamate. Nature 1986, 321, 772-773. [CrossRef] [PubMed]
8. Featherstone, D.E.; Shippy, S.A. Regulation of synaptic transmission by ambient extracellular glutamate. Neuroscientist 2008, 14, 171-181. [CrossRef] [PubMed]
9. Zhou, Y.; Danbolt, N.C. Glutamate as a neurotransmitter in the healthy brain. J. Neural Transm. 2014, 121, 799-817. [CrossRef] [PubMed]
10. Oldendorf,W.H.; Szabo, J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 1976, 230, 94-98. [PubMed]
11. Márquez, J.; Cardona, C.; Campos-Sandoval, J.A.; Peñalver, A.; Tosina, M.; Matés, J.M.; Martín-Rufián, M. Mammalian glutaminase isozymes in brain. Metab. Brain Dis. 2013, 28, 133-137. [CrossRef] [PubMed]
12. Spanaki, C.; Kotzamani, D.; Petraki, Z.; Drakos, E.; Plaitakis, A. Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues. Neurochem. Res. 2014, 39, 500-515. [CrossRef] [PubMed]
13. Cooper, A.J.L.; Plum, F. Biochemistry and Physiology of brain ammonia. Physiol. Rev. 1997, 67, 440-519.
14. Cooper, A.J.L.; McDonald, J.M.; Gelbard, A.S.; Gledhill, R.F.; Duffy, T.E. The metabolic fate of 13N-labeled ammonia in rat brain. J. Biol. Chem. 1979, 254, 4982-4992. [PubMed]
15. Plaitakis, A.; Zaganas, I. Regulation of human glutamate dehydrogenases: Implications for glutamate, ammonia and energy metabolism in brain. J. Neurosci. Res. 2001, 66, 899-908. [CrossRef] [PubMed]
16. Cooper, A.J.L. 13N as a tracer for studying glutamate metabolism. Neurochem. Int. 2011, 59, 456-464. [CrossRef] [PubMed]
17. Felig, P.;Wahren, J.; Ahlborg, G. Uptake of individual amino acids by the human brain. Proc. Soc. Exp. Biol. Med. 1973, 142, 230-231. [CrossRef] [PubMed]
18. Braunstein, A.E. Les voies principales de l'assimilation et dissimilation de l'azote chez les animaux. Adv. Enzymol. Relat. Subj. Biochem. 1957, 19, 335-389. [PubMed]
19. Cooper, A.J.L.; Meister, A. An appreciation of Professor Alexander E. Braunstein. The discovery and scope of enzymatic transamination. Biochimie 1989, 71, 387-404. [CrossRef]
20. Cooper, A.J.L. The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem. Res. 2012, 37, 2439-2455. [CrossRef] [PubMed]
21. Cooper, A.J.L.; Mora, S.N.; Cruz, N.F.; Gelbard, A.S. Cerebral ammonia metabolism in hyperammonemic rats. J. Neurochem. 1985, 44, 1716-1723. [CrossRef] [PubMed]
22. Dadsetan, S.; Kukolj, E.; Bak, L.K.; Sørensen, M.; Ott, P.; Vilstrup, H.; Schousboe, A.; Keiding, S.; Waagepetersen, H.S. Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: Effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures. J. Cereb. Blood Flow Metab. 2013, 33, 1235-1241. [CrossRef] [PubMed]
23. Sweatt, A.J.;Wood, M.; Suryawan, A.;Wallin, R.;Willingham, M.C.; Hutson, S.M. Branched-chain amino acid catabolism: Unique segregation of pathway enzymes in organ systems and peripheral nerves. Am. J. Physiol. Endocrinol. Metab. 2004, 286, E64-E76. [CrossRef] [PubMed]
24. Hull, J.; Patel, V.B.; Hutson, S.M.; Conway, M.E. New insights into the role of the branched-chain aminotransferase proteins in the human brain. J. Neurosci. Res. 2015, 93, 987-998. [CrossRef] [PubMed]
25. Van derWerf, P.; Meister, A. The metabolic formation and utilization of 5-oxo-L-proline (L-pyroglutamate, L-pyrrolidone carboxylate). Adv. Enzymol. Relat. Areas Mol. Biol. 1975, 43, 519-556. [PubMed]
26. Li, L.Y.; Seddon, A.P.; Meister, A.; Inubushi, T. Study of the 5-oxoprolinase reaction by 13C NMR. J. Biol. Chem. 1989, 264, 3096-3101. [PubMed]
27. Orlowski, M.;Wilk, S. Intermediates of the-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and-glutamyl amino acids. Eur. J. Biochem. 1975, 53, 581-590. [CrossRef] [PubMed]
28. Bowser, T.E.; Trawick, M.L. Probing the specificity of-glutamylamine cyclotransferase: An enzyme involved in the metabolism of transglutaminase-catalyzed protein crosslinks. Amino Acids 2013, 44, 143-150. [CrossRef] [PubMed]
29. Sasaki, S.; Futagi, Y.; Kobayashi, M.; Ogura, J.; Iseki, K. Functional characterization of 5-oxoproline transport via SLC16A1/MCT1. J. Biol. Chem. 2015, 290, 2303-2311. [CrossRef] [PubMed]
30. Wilk, S.; Orlowski, M. Determination of pyrrolidone carboxylate and-glutamyl amino acids by gas chromatography. Anal. Biochem. 1975, 69, 100-113. [CrossRef]
31. Cooper, A.J.L.; Dhar, A.K.; Kutt, H.; Duffy, T.E. Determination of 2-pyrrolidone-5-carboxylic and α-ketoglutaramic acids in human cerebrospinal fluid by gas chromatography. Anal. Biochem. 1980, 103, 118-126. [CrossRef]
32. Hook, G.; Yu, J.; Toneff, T.; Kindy, M.; Hook, V. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J. Alzheimers Dis. 2014, 41, 129-149. [PubMed]
33. Pivtoraiko, V.N.; Abrahamson, E.E.; Leurgans, S.E.; DeKosky, S.T.; Mufson, E.J.; Ikonomovic, M.D. Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease. Neurobiol. Aging 2015, 36, 12-19. [CrossRef] [PubMed]
34. Levintow, L.; Meister, A. Reversibility of the enzymatic synthesis of glutamine. J. Biol. Chem. 1954, 209, 265-280. [PubMed]
35. Wang, Y.; Kudoh, J.; Kubota, R.; Asakawa, S.; Minoshima, S.; Shimizu, N. Chromosomal mapping of a family of human glutamine synthetase genes: Functional gene (GLUL) on 1q25, pseudogene (GLULP) on 9p13, and three related genes (GLULL1, GLULL2, GLULL3) on 5q33, 11p15, and 11q24. Genomics 1996, 37, 195-199. [PubMed]
36. Boksha, I.S.; Tereshkina, E.B.; Burbaeva, G.S. Glutamine synthetase and glutamine synthetase-like protein from human brain: Purification and comparative characterization. J. Neurochem. 2000, 75, 2574-2582. [CrossRef] [PubMed]
37. Boksha, I.S.; Schönfeld, H.J.; Langen, H.; Müller, F.; Tereshkina, E.B.; Burbaeva, G.S. Glutamine synthetase isolated from human brain: Octameric structure and homology of partial primary structure with human liver glutamine synthetase. Biochemistry (Mosc.) 2002, 67, 1012-1020. [CrossRef] [PubMed]
38. Meister, A. Glutamine synthetase from mammalian tissues. Adv. Enzymol. Relat. Areas Mol. Biol. 1985, 113, 185-199.
39. Shin, D.; Park, C. N-terminal extension of canine glutamine synthetase created by splicing alters its enzymatic property. J. Biol. Chem. 2004, 279, 1184-1190. [CrossRef] [PubMed]
40. Jeitner, T.M.; Battaile, K.; Cooper, A.J.L. Critical evaluation of the changes in glutamine synthetase activity in models of cerebral stroke. Neurochem. Res. 2015, 40, 2544-2556. [CrossRef] [PubMed]
41. Martinez-Hernandez, A.; Bell, K.P.; Norenberg, M.D. Glutamine synthetase: Glial localization in brain. Science 1977, 195, 1356-1358. [CrossRef] [PubMed]
42. Norenberg, M.D.; Martinez-Hernandez, A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 1979, 161, 303-310. [CrossRef]
43. Bernstein, H.G.; Bannier, J.; Meyer-Lotz, G.; Steiner, J.; Keilhoff, G.; Dobrowolny, H.;Walter, M.; Bogerts, B. Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization. J. Chem. Neuroanat. 2014, 61, 33-50. [CrossRef] [PubMed]
44. Robinson, S.R. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem. Int. 2000, 36, 471-482. [CrossRef]
45. Robinson, S.R. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J. Neurosci. Res. 2001, 66, 972-980. [CrossRef] [PubMed]
46. Parli, J.A.; Godfrey, D.A.; Ross, C.D. Separate enzymatic microassays for aspartate aminotransferase isoenzymes. Biochim. Biophys. Acta 1987, 925, 175-184. [CrossRef]
47. Fitzpatrick, S.M.; Cooper, A.J.L.; Duffy, T.E. Use of β-methylene-D,L-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J. Neurochem. 1983, 41, 1370-1383. [CrossRef] [PubMed]
48. Cheeseman, A.J.; Clark, J.B. Influence of the malate-aspartate shuttle on oxidative metabolism in synaptosomes. J. Neurochem. 1988, 50, 1559-1565. [CrossRef] [PubMed]
49. Williamson, D.H.; Lund, P.; Krebs, H.A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 1967, 103, 514-527. [CrossRef] [PubMed]
50. Treberg, J.R.; Brosnan, M.E.; Watford, M.; Brosnan, J.T. On the reversibility of glutamate dehydrogenase and the source of hyperammonemia in the hyperinsulinism/hyperammonemia syndrome. Adv. Enzyme Regul. 2010, 50, 34-43. [CrossRef] [PubMed]
51. Howse, D.C.; Duffy, T.E. Control of the redox state of the pyridine nucleotides in the rat cerebral cortex. Effect of electroshock-induced seizures. J. Neurochem. 1975, 24, 935-940. [CrossRef] [PubMed]
52. Erecińska, M.; Pleasure, D.; Nelson, D.; Nissim, I.; Yudkoff, M. Cerebral aspartate utilization: Near-equilibrium relationships in aspartate aminotransferase reaction. J. Neurochem. 1993, 60, 1696-1706. [CrossRef] [PubMed]
53. Cooper, A.J.L.; Nieves, E.; Coleman, A.E.; Filc-DeRicco, S.; Gelbard, A.S. Short-term metabolic fate of [13N]ammonia in rat liver in vivo. J. Biol. Chem. 1987, 262, 1073-1080. [PubMed]
54. Fell, D.A. Enzymes, metabolites and fluxes. J. Exp. Bot. 2005, 56, 267-272. [CrossRef] [PubMed]
55. Duffy, T.E.; Plum, F.; Cooper, A.J.L. Cerebral ammonia metabolism in vivo. In Glutamine, Glutamate and GABA in the Central Nervous System; Hertz, L., Kvamme, E., McGeer, E.G., Schousboe, A., Eds.; Alan R. Liss, Inc.: New York, NY, USA, 1983; pp. 371-388.
56. Spanaki, C.; Kotzamani, D.; Kleopa, K.; Plaitakis, A. Evolution of GLUD2 glutamate dehydrogenase allows expression in human cortical neurons. Mol. Neurobiol. 2015. [CrossRef] [PubMed]
57. Spanaki, C.; Kotzamani, D.; Petraki, Z.; Drakos, E.; Plaitakis, A. Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. Mol. Cell. Endocrinol. 2015, 415, 1-11. [CrossRef] [PubMed]
58. Arevalo, M.A.; Azcoitia, I.; Garcia-Segura, L.M. The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 2015, 16, 17-29. [CrossRef] [PubMed]
59. Lowenstein, J.M. Ammonia production in muscle and other tissues: The purine nucleotide cycle. Physiol. Rev. 1972, 52, 382-414. [PubMed]
60. Schultz, V.; Lowenstein, J.M. Purine nucleotide cycle. Evidence for the occurrence of the cycle in brain. J. Biol. Chem. 1976, 251, 485-492. [PubMed]
61. Schultz, V.; Lowenstein, J.M. The purine nucleotide cycle. Studies of ammonia production and interconversions of adenine and hypoxanthine nucleotides and nucleosides by rat brain in situ. J. Biol. Chem. 1978, 253, 1938-1943. [PubMed]
62. Zulfiqar, M.; Lin, D.D.; Van der Graaf, M.; Barker, P.B.; Fahrner, J.A.; Marie, S.; Morava, E.; De Boer, L.; Willemsen, M.A.; Vining, E.; et al. Novel proton MR spectroscopy findings in adenylosuccinate lyase deficiency. J. Magn. Reson. Imag. 2013, 37, 974-980. [CrossRef] [PubMed]
63. Knecht, K.;Wiesmüller, K.H.; Gnau, V.; Jung, G.; Meyermann, R.; Todd, K.G.; Hamprecht, B. AMP deaminase in rat brain: Localization in neurons and ependymal cells. J. Neurosci. Res. 2001, 66, 941-950. [CrossRef] [PubMed]
64. Lowenstein, J.M.; Goodman, M.N. The purine nucleotide cycle in skeletal muscle. Fed. Proc. 1978, 37, 2308-2312. [PubMed]
65. Müller, A.F.; Leuthardt, F. Die Umwandlung der Glutaminsaure in Asparaginsaure in den Mitochondrien der Leber. (mit Bemerkung über das Vorkommen einer Transaminase in Clostridium Welchii). Helv. Chim. Acta 1950, 33, 268-273. [CrossRef]
66. Kishore, N.; Tewari, Y.B.; Goldberg, R.N. An investigation of the equilibrium of the reaction {L-aspartate(aq)+2-oxoglutarate(aq)=oxaloacetate(aq)+L-glutamate(aq)}. J. Chem. Thermodyn. 1978, 30, 1373-1384. [CrossRef]
67. Lowenstein, J.M. The tricarboxylic acid cycle. In Metabolic Pathways, 3rd ed.; Greenberg, D.M., Ed.; Academic Press: New York, NY, USA, 1967; Volume 1, pp. 146-270.
68. Cooper, A.J.L. L-Glutamate (2-oxoglutarate) aminotransferases. In Glutamine and Glutamate in Mammals; Kwamme, E., Ed.; CRC Press, Inc.: Boca Raton, FL, USA, 1981; Volume I, pp. 445-461.
69. Balázs, R.; Machiyama, Y.; Hammond, B.J.; Julian, T.; Richter, D. The operation of the-aminobutyrate bypath of the tricarboxylic acid cycle in brain tissue in vitro. Biochem. J. 1970, 116, 445-461. [PubMed]
70. Salminen, A.; Jouhten, P.; Sarajärvi, T.; Haapasalo, A.; Hiltunen, M. Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease. Neurochem. Int. 2016, 92, 13-24. [CrossRef] [PubMed]
71. Douglas, G.W.; Mortensen, R.A. The rate of metabolism of brain and liver glutathione in the rat studied with C14-glycine. J. Biol. Chem. 1956, 222, 581-585. [PubMed]
72. Rehncrona, S.; Folbergrová, J.; Smith, D.S.; Siesjö, B.K. Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J. Neurochem. 1980, 34, 477-486. [CrossRef] [PubMed]
73. Cooper, A.J.L.; Pulsinelli, W.A.; Duffy, T.E. Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J. Neurochem. 1980, 35, 1242-1245. [CrossRef] [PubMed]
74. Guitart, K.; Loers, G.; Schachner, M.; Kleene, R. Prion protein regulates glutathione metabolism and neural glutamate and cysteine uptake via excitatory amino acid transporter 3. J. Neurochem. 2015, 133, 558-571. [CrossRef] [PubMed]
75. Rice, M.E.; Russo-Menna, I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 1998, 82, 1213-1223. [CrossRef]
76. Sun, X.; Shih, A.Y.; Johannssen, H.C.; Erb, H.; Li, P.; Murphy, T.H. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J. Biol. Chem. 2006, 281, 17420-17431. [CrossRef] [PubMed]
77. Dringen, R.; Pfeiffer, B.; Hamprecht, B. Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 1999, 19, 562-569. [PubMed]
78. Dringen, R. Hirrlinger J Glutathione pathways in the brain. Biol. Chem. 2003, 384, 505-516. [CrossRef] [PubMed]
79. Chen, Y.; Swanson, R.A. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J. Neurochem. 2003, 84, 1332-1339. [CrossRef] [PubMed]
80. Ye, Z.C.; Rothstein, J.D.; Sontheimer, H. Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 1999, 19, 10767-10777. [PubMed]
81. Glowatzki, E.; Cheng, N.; Hiel, H.; Yi, E.; Tanaka, K.; Ellis-Davies, G.C.; Rothstein, J.D.; Bergles, D.E. The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea. J. Neurosci. 2006, 26, 7659-7564. [CrossRef] [PubMed]
82. Benediktsson, A.M.; Marrs, G.S.; Tu, J.C.;Worley, P.F.; Rothstein, J.D.; Bergles, D.E.; Dailey, M.E. Neuronal activity regulates glutamate transporter dynamics in developing astrocytes. Glia 2012, 60, 175-188. [CrossRef] [PubMed]
83. Fuhrmann, M.; Bittner, T.; Mitteregger, G.; Haider, N.; Moosmang, S.; Kretzschmar, H.; Herms, J. Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons. J. Neurochem. 2006, 98, 1876-1885. [CrossRef] [PubMed]
84. Krebs, B.; Wiebelitz, A.; Balitzki-Korte, B.; Vassallo, N.; Paluch, S.; Mitteregger, G.; Onodera, T.; Kretzschmar, H.A.; Herms, J. Cellular prion protein modulates the intracellular calcium response to hydrogen peroxide. J. Neurochem. 2007, 100, 358-367. [CrossRef] [PubMed]
85. Harris, J.L.; Choi, I.Y.; Brooks, W.M. Probing astrocyte metabolism in vivo: Proton magnetic resonance spectroscopy in the injured and aging brain. Front. Aging Neurosci. 2015. [CrossRef] [PubMed]
86. Mason, G.F.; Rothman, D.L.; Behar, K.L.; Shulman, R.G. NMR determination of the TCA cycle rate and α-ketoglutarate/glutamate exchange rate in rat brain. J. Cereb. Blood Flow Metab. 1992, 12, 434-447. [CrossRef] [PubMed]
87. Mason, G.F.; Gruetter, R.; Rothman, D.L.; Behar, K.L.; Shulman, R.G.; Novotny, E.J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, α-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J. Cereb. Blood Flow Metab. 1995, 15, 12-25. [CrossRef] [PubMed]
88. Xin, L.; Lanz, B.; Lei, H.; Gruetter, R. Assessment of metabolic fluxes in the mouse brain in vivo using 1H-[13C] NMR spectroscopy at 14.1 Tesla. J. Cereb. Blood Flow Metab. 2015, 35, 759-765. [CrossRef] [PubMed]
89. Pamiljans, V.; Krishnaswamy, P.R.; Dumville, G.; Meister, A. Studies on the mechanism of glutamine synthesis; isolation and properties of the enzyme from sheep brain. Biochemistry 1962, 1, 153-158. [CrossRef] [PubMed]
90. Raichle, M.E.; Larson, K.B. The significance of the NH3-NH4 + equilibrium on the passage of 13N-ammonia from blood to brain. A new regional residue detection model. Circ. Res. 1981, 48, 913-937. [CrossRef] [PubMed]
91. Girard, G.; Giguère, J.F.; Butterworth, R.F. Region-selective reductions in activities of glutamine synthetase in rat brain following portacaval anastomosis. Metab. Brain Dis. 1993, 8, 207-215. [CrossRef] [PubMed]
92. Butterworth, R.F.; Lavoie, J.; Layrargues, G.P.; Giguère, J.F. Cerebral amino acid changes in hepatic encephalopathy: Biochemical-neuropathological correlations. In Biochemical Pathology of the Astrocytes; Norenberg, M.D., Hertz, L., Schousboe, A., Eds.; Alan R. Liss, Inc.: New York, NY, USA, 1983; pp. 481-482.
93. Singh, S.; Mondal, P.; Trigun, S.K. Acute liver failure in rats activates glutamine-glutamate cycle but declines antioxidant enzymes to induce oxidative stress in cerebral cortex and cerebellum. PLoS ONE 2014, 9, e95855. [CrossRef] [PubMed]
94. Gjedde, A.; Lockwood, A.H.; Duffy, T.E.; Plum, F. Cerebral blood flow and metabolism in chronically hyperammonemic rats: Effect of an acute ammonia challenge. Ann. Neurol. 1978, 3, 325-330. [CrossRef] [PubMed]
95. Hindfelt, B.; Plum, F.; Duffy, T.E. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J. Clin. Investig. 1977, 59, 386-396. [CrossRef] [PubMed]
96. Butterworth, R.F.; Giguère, J.F. Cerebral aminoacids in portal-systemic encephalopathy: Lack of evidence for altered-aminobutyric acid (GABA) function. Metab. Brain Dis. 1986, 1, 221-228. [CrossRef] [PubMed]
97. Cudalbu, C.; Lanz, B.; Duarte, J.M.; Morgenthaler, F.D.; Pilloud, Y.; Mlynárik, V.; Gruetter, R. Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized 1H and 15N NMR spectroscopy. J. Cereb. Blood Flow Metab. 2012, 32, 696-708. [CrossRef] [PubMed]
98. Mardini, H.; Smith, F.E.; Record, C.O.; Blamire, A.M. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J. Hepatol. 2011, 54, 1154-1160. [CrossRef] [PubMed]
99. Chavarria, L.; Alonso, J.; García-Martínez, R.; Simón-Talero, M.; Ventura-Cots, M.; Ramírez, C.; Torrens, M.; Vargas, V.; Rovira, A.; Córdoba, J. Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J. Cereb. Blood Flow Metab. 2013, 33, 272-277. [CrossRef] [PubMed]
100. Ratnakumari, L.; Qureshi, I.A.; Butterworth, R.F. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem. Biophys. Res. Commun. 1992, 184, 746-751. [CrossRef]
101. Lai, J.C.K.; Cooper, A.J.L. Brain α-ketoglutarate dehydrogenase complex: Kinetic properties, regional distribution, and effects of inhibitors. J. Neurochem. 1986, 47, 1376-1386. [CrossRef] [PubMed]
102. Cooper, A.J.L.; Vergara, F.; Duffy, T.E. Cerebral glutamine synthetase. In Glutamine, Glutamate and GABA in the Central Nervous System; Hertz, L., Kvamme, E., McGeer, E.G., Schousboe, A., Eds.; Alan R. Liss, Inc.: New York, NY, USA, 1983; pp. 77-93.
103. Bak, L.K.;Waagepetersen, H.S.; Sørensen, M.; Ott, P.; Vilstrup, H.; Keiding, S.; Schousboe, A. Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy. Metab. Brain Dis. 2013, 28, 209-215. [CrossRef] [PubMed]
104. Hassel, B. Carboxylation and anaplerosis in neurons and glia. Mol. Neurobiol. 2000, 22, 21-40. [CrossRef]
105. Hassel, B.; Bråthe, A. Neuronal pyruvate carboxylation supports formation of transmitter glutamate. J. Neurosci. 2000, 20, 1342-1347. [PubMed]
106. Hassel, B.; Bråthe, A. Cerebral metabolism of lactate in vivo: Evidence for neuronal pyruvate carboxylation. J. Cereb. Blood Flow Metab. 2000, 20, 327-336. [CrossRef] [PubMed]
107. McKenna, M.C.; Stevenson, J.H.; Huang, X.; Tildon, J.T.; Zielke, C.L.; Hopkins, I.B. Mitochondrial malic enzyme activity is much higher in mitochondria from cortical synaptic terminals compared with mitochondria from primary cultures of cortical neurons or cerebellar granule cells. Neurochem. Int. 2000, 36, 451-459. [CrossRef]
108. Dienel, G.A.; McKenna, M.C. A dogma-breaking concept: Glutamate oxidation in astrocytes is the source of lactate during aerobic glycolysis in resting subjects. J. Neurochem. 2014, 131, 395-398. [CrossRef] [PubMed]
109. Sonnewald, U. Glutamate synthesis has to be matched by its degradation-Where do all the carbons go? J. Neurochem. 2014, 131, 399-406. [CrossRef] [PubMed]
110. Yu, A.C.; Drejer, J.; Hertz, L.; Schousboe, A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem. 1983, 41, 1484-1487. [CrossRef] [PubMed]
111. Shank, R.P.; Bennett, G.S.; Freytag, S.O.; Campbell, G.L. Pyruvate carboxylase: An astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res. 1985, 329, 364-367. [CrossRef]
112. Schousboe, A.; Scafidi, S.; Bak, L.K.; Waagepetersen, H.S.; McKenna, M.C. Glutamate metabolism in the brain focusing on astrocytes. Adv. Neurobiol. 2014, 11, 13-30. [PubMed]
113. Öz, G.; Berkich, D.A.; Henry, P.G.; Xu, Y.; LaNoue, K.; Hutson, S.M.; Gruetter, R. Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. J. Neurosci. 2004, 24, 11273-11279. [CrossRef] [PubMed]
114. Lanz, B.; Xin, L.; Millet, P.; Gruetter, R. In vivo quantification of neuro-glial metabolism and glial glutamate concentration using 1H-[13C] MRS at 14.1T. J. Neurochem. 2014, 128, 125-139. [CrossRef] [PubMed]
115. Gruetter, R.; Seaquist, E.R.; Kim, S.; Ugurbil, K. Localized in vivo 13C-NMR of glutamate metabolism in the human brain: Initial results at 4Tesla. Dev. Neurosci. 1998, 20, 380-388. [CrossRef] [PubMed]
116. Gruetter, R.; Seaquist, E.R.; Ugurbil, K. A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am. J. Physiol. Endocrinol. Metab. 2001, 281, E100-E112. [PubMed]
117. Aureli, T.; Di Cocco, M.E.; Calvani, M.; Conti, F. The entry of [1-13C]glucose into biochemical pathways reveals a complex compartmentation and metabolite trafficking between glia and neurons: A study by 13C-NMR spectroscopy. Brain Res. 1997, 765, 218-227. [CrossRef]
118. Sibson, N.R.; Mason, G.F.; Shen, J.; Cline, G.W.; Herskovits, A.Z.; Wall, J.E.; Behar, K.L.; Rothman, D.L.; Shulman, R.G. In vivo 13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2-13C]glucose infusion. J. Neurochem. 2001, 76, 975-989. [CrossRef] [PubMed]
119. Lapidot, A.; Gopher, A. Cerebral metabolic compartmentation. Estimation of glucose flux via pyruvate carboxylase/pyruvate dehydrogenase by 13C NMR isotopomer analysis of D-[U-13C]glucose metabolites. J. Biol. Chem. 1994, 269, 27198-27208. [PubMed]
120. Clark, G.M.; Eiseman, B. Studies in ammonia metabolism. IV. Biochemical changes in brain tissue of dogs during ammonia induced coma. New Engl. J. Med. 1958, 259, 178-180. [CrossRef] [PubMed]
121. Berl, S.; Takagaki, G.; Clarke, D.D.; Waelsch, H. Carbon dioxide fixation in the brain. J. Biol. Chem. 1962, 237, 2570-2573. [PubMed]
122. Sarma, M.K.; Huda, A.; Nagarajan, R.; Hinkin, C.H.;Wilson, N.; Gupta, R.K.; Frias-Martinez, E.; Sayre, J.; Guze, B.; Han, S.H.; et al. Multi-dimensional MR spectroscopy: Towards a better understanding of hepatic encephalopathy. Metab. Brain Dis. 2011, 26, 173-184. [CrossRef] [PubMed]
123. Lin, W.C.; Chou, K.H.; Chen, C.L.; Chen, H.L.; Lu, C.H.; Li, S.H.; Huang, C.C.; Lin, C.P.; Cheng, Y.F. Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation. PLoS ONE 2014, 9, e105887. [CrossRef] [PubMed]
124. Schousboe, A.; Waagepetersen, H.S.; Leke, R.; Bak, L.K. Effects of hyperammonemia on brain energy metabolism: Controversial findings in vivo and in vitro. Metab. Brain Dis. 2014, 29, 913-917. [CrossRef] [PubMed]
125. Ott, P.; Vilstrup, H. Cerebral effects of ammonia in liver disease: Current hypotheses. Metab. Brain Dis. 2014, 29, 901-911. [CrossRef] [PubMed]
126. Fitzpatrick, S.M.; Hetherington, H.P.; Behar, K.L.; Shulman, R.G. Effects of acute hyperammonemia on cerebral amino acid metabolism and pHi in vivo, measured by 1H and 31P nuclear magnetic resonance. J. Neurochem. 1989, 52, 741-749. [CrossRef] [PubMed]
127. Rackayova, V.; Braissant, O.; McLin, V.A.; Berset, C.; Lanz, B.; Cudalbu, C. 1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: In vivo longitudinal measurements of brain energy metabolism. Metab. Brain Dis. 2015. [CrossRef] [PubMed]
128. Brusilow, S.W.; Koehler, R.C.; Traystman, R.J.; Cooper, A.J.L. Astrocyte glutamine synthetase: Importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010, 7, 452-470. [CrossRef] [PubMed]
129. Butterworth, R.F. Pathophysiology of brain dysfunction in hyperammonemic syndromes: The many faces of glutamine. Mol. Genet. Metab. 2014, 113, 113-117. [CrossRef] [PubMed]
130. Bosoi, C.R.; Zwingmann, C.; Marin, H.; Parent-Robitaille, C.; Huynh, J.; Tremblay, M.; Rose, C.F. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J. Hepatol. 2014, 60, 554-560. [CrossRef] [PubMed]
131. Berl, S.; Takagaki, G.; Clarke, D.D.;Waelsch, H. Metabolic compartments in vivo. Ammonia and glutamic acid metabolism in brain and liver. J. Biol. Chem. 1962, 237, 2562-2569. [PubMed]
132. Benjamin, A.M.; Quastel, J.H. Metabolism of amino acids and ammonia in rat brain cortex slices in vitro: A possible role of ammonia in brain function. J. Neurochem. 1975, 25, 197-206. [CrossRef] [PubMed]
133. Nagaraja, T.N.; Brookes, N. Intracellular acidification induced by passive and active transport of ammonium ions in astrocytes. Am. J. Physiol. 1998, 274, C883-C891. [PubMed]
134. Rothman, D.L.; De Feyter, H.M.; de Graaf, R.A.; Mason, G.F.; Behar, K.L. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed. 2011, 24, 943-957. [CrossRef] [PubMed]
135. Patel, A.B.; de Graaf, R.A.; Mason, G.F.; Rothman, D.L.; Shulman, R.G.; Behar, K.L. The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc. Natl. Acad. Sci. USA 2005, 102, 5588-5593. [CrossRef] [PubMed]
136. Erecińska, M.; Zaleska, M.M.; Nissim, I.; Nelson, D.; Dagani, F.; Yudkoff, M. Glucose and synaptosomal glutamate metabolism: Studies with [15N]glutamate. J. Neurochem. 1988, 51, 892-902. [CrossRef] [PubMed]
137. Ward, H.K.; Bradford, H.F. Relative activities of glutamine synthetase and glutaminase in mammalian synaptosomes. J. Neurochem. 1979, 33, 339-342. [CrossRef] [PubMed]
138. Dennis, S.C.; Lai, J.C.K.; Clark, J.B. The distribution of glutamine synthetase in subcellular fractions of rat brain. Brain Res. 1980, 197, 469-475. [CrossRef]
139. Tranah, T.H.; Vijay, G.K.; Ryan, J.M.; Shawcross, D.L. Systemic inflammation and ammonia in hepatic encephalopathy. Metab. Brain Dis. 2013, 28, 1-5. [CrossRef] [PubMed]
140. Jayakumar, A.R.; Rama Rao, K.V.; Norenberg, M.D. Neuroinflammation in hepatic encephalopathy: Mechanistic aspects. J. Clin. Exp. Hepatol. 2015, 5, S21-S28. [CrossRef] [PubMed]
141. Nakajima, K.; Kanamatsu, T.; Takezawa, Y.; Kohsaka, S. Up-regulation of glutamine synthesis in microglia activated with endotoxin. Neurosci. Lett. 2015, 591, 99-104. [CrossRef] [PubMed]
142. Morioka, N.; Harano, S.; Tokuhara, M.; Idenoshita, Y.; Zhang, F.F.; Hisaoka-Nakashima, K.; Nakata, Y. Stimulation of α7 nicotinic acetylcholine receptor regulates glutamate transporter GLAST via basic fibroblast growth factor production in cultured cortical microglia. Brain Res. 2015, 1625, 111-120. [CrossRef] [PubMed]
143. Beaulieu, C.; Somogyi, P. Targets and quantitative distribution of gabaergic synapses in the visual cortex of the cat. Eur. J. Neurosci. 1990, 2, 296-303. [CrossRef] [PubMed]
144. Walls, A.B.; Waagepetersen, H.S.; Bak, L.K.; Schousboe, A.; Sonnewald, U. The glutamine-glutamate/GABA cycle: Function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism. Neurochem. Res. 2015, 40, 402-409. [CrossRef] [PubMed]
145. Berl, S.; Frigyesi, T.L. The turnover of glutamate, glutamine, aspartate and GABA labeled with [1-14C]acetate in caudate nucleus, thalamus and motor cortex (cat). Brain Res. 1969, 12, 444-455. [CrossRef]
146. Van den Berg, C.J.; Krzalic, L.; Mela, P.;Waelsch, H. Compartmentation of glutamate metabolism in brain. Evidence for the existence of two different tricarboxylic acid cycles in brain. Biochem. J. 1969, 113, 281-290. [CrossRef] [PubMed]
147. Van den Berg, C.J.; Ronda, G. The incorporation of double-labelled acetate into glutamate ad related amino acids from adult mouse brain: Compartmentation of amino acid metabolism in brain. J. Neurochem. 1976, 27, 1443-1448. [CrossRef] [PubMed]
148. Wyss, M.T.; Magistretti, P.J.; Buck, A.; Weber, B. Labeled acetate as a marker of astrocytic metabolism. J. Cereb. Blood Flow Metab. 2011, 31, 1668-1674. [CrossRef] [PubMed]
149. Badar-Goffer, R.S.; Bachelard, H.S.; Morris, P.G. Cerebral metabolism of acetate and glucose studied by 13C-n.m.r. spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem. J. 1990, 266, 133-139. [CrossRef] [PubMed]
150. Sonnewald, U.; Westergaard, N.; Hassel, B.; Muller, T.B.; Unsgard, G.; Fonnum, F.; Hertz, L.; Schousboe, A.; Petersen, S.B. NMR spectroscopic studies of 13C acetate and 13C glucose metabolism in neocortical astrocytes: Evidence for mitochondrial heterogeneity. Dev. Neurosci. 1993, 15, 351-358. [CrossRef] [PubMed]
151. Sonnewald, U.; Westergaard, N.; Schousboe, A.; Svendsen, J.S.; Unsgard, G.; Petersen, S.B. Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem. Int. 1993, 22, 19-29. [CrossRef]
152. Waniewski, R.A.; Martin, D.L. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 1998, 18, 5225-5233. [PubMed]
153. Waniewski, R.A.; Martin, D.L. Astrocytes and synaptosomes transport and metabolize lactate and acetate differently. Neurochem. Res. 2004, 29, 209-217. [CrossRef] [PubMed]
154. Calvetti, D.; Somersalo, E. Quantitative in silico analysis of neurotransmitter pathways under steady state conditions. Front. Endocrinol. (Lausanne) 2013. [CrossRef] [PubMed]
155. Cooper, A.J.L. Quantitative analysis of neurotransmitter pathways under steady state conditions-A perspective. Front. Endocrinol. (Lausanne) 2013. [CrossRef] [PubMed]
156. Benuck, M.; Lajtha, A. Aminotransferase activity in brain. Int. Rev. Neurobiol. 1975, 17, 85-129. [PubMed]
157. Segal, H.L.; Beattie, D.S.; Hopper, S. Purification and properties of liver glutamic-alanine transaminase from normal and corticoid-treated rats. J. Biol. Chem. 1962, 237, 1914-1920.
158. Fries, A.W.; Dadsetan, S.; Keiding, S.; Bak, L.K.; Schousboe, A.;Waagepetersen, H.S.; Simonsen, M.; Ott, P.; Vilstrup, H.; Sørensen, M. Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats. J. Cereb. Blood Flow Metab. 2014, 34, 460-466. [CrossRef] [PubMed]
159. Hutson, S.M.; Berkich, D.; Drown, P.; Xu, B.; Aschner, M.; LaNoue, K.F. Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J. Neurochem. 1998, 71, 863-874. [CrossRef] [PubMed]
160. Hutson, S.M.; Lieth, E.; LaNoue, K.F. Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J. Nutr. 2001, 131, 846S-850S. [PubMed]
161. Berl, S.; Frigyesi, T.L. Metabolism of [14C]leucine and [14C]acetate in sensorimotor cortex, thalamus, caudate nucleus and cerebellum of the cat. J. Neurochem. 1968, 15, 965-970. [CrossRef] [PubMed]
162. Berl, S.; Frigyesi, T.L. Comparison of cerebral regional metabolism of [14C]leucine following third ventricle and intravenous administration in the cat. J. Neurochem. 1969, 16, 405-415. [CrossRef] [PubMed]
163. Yudkoff, M.; Daikhin, Y.; Grunstein, L.; Nissim, I.; Stern, J.; Pleasure, D.; Nissim, I. Astrocyte leucine metabolism: Significance of branched-chain amino acid transamination. J. Neurochem. 1996, 66, 378-385. [CrossRef] [PubMed]
164. Yudkoff, M.; Daikhin, Y.; Nissim, I.; Horyn, O.; Luhovyy, B.; Lazarow, A.; Nissim, I. Brain amino acid requirements and toxicity: The example of leucine. J. Nutr. 2005, 135, 1531S-1538S. [PubMed]
165. Rothman, D.L.; De Feyter, H.M.; Maciejewski, P.K.; Behar, K.L. Is there in vivo evidence for amino acid shuttles carrying ammonia from neurons to astrocytes? Neurochem. Res. 2012, 37, 2597-2612. [CrossRef] [PubMed]
166. Pardo, B.; Rodrigues, T.B.; Contreras, L.; Garzón, M.; Llorente-Folch, I.; Kobayashi, K.; Saheki, T.; Cerdan, S.; Satrústegui, J. Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation. J. Cereb. Blood Flow Metab. 2011, 31, 90-101. [CrossRef] [PubMed]
167. Hertz, L. Brain glutamine synthesis requires neuronal aspartate: A commentary. J. Cereb. Blood Flow Metab. 2011, 31, 384-387. [CrossRef] [PubMed]
168. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev. 1999, 51, 7-61. [PubMed]
169. Greenamyre, J.T.; Porter, R.H. Anatomy and physiology of glutamate in the CNS. Neurology 1994, 44, S7-S13. [PubMed]
170. Olney, J.W.; Sharpe, L.G. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 1969, 166, 386-388. [CrossRef] [PubMed]
171. Olney, J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164, 719-721. [CrossRef] [PubMed]
172. Olney, J.W. Inciting excitotoxic cytocide among central neurons. Adv. Exp. Med. Biol. 1986, 203, 631-645. [PubMed]
173. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1, 623-634. [CrossRef]
174. Nicholls, D.; Attwell, D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 1990, 11, 462-468. [CrossRef]
175. Meldrum, B.; Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 1990, 11, 379-387. [CrossRef]
176. Lipton, S.A.; Rosenberg, P.A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 1994, 330, 613-622. [PubMed]
177. Lewerenz, J.; Maher, P. Chronic glutamate toxicity in neurodegenerative diseases-What is the evidence? Front. Neurosci. 2015. [CrossRef] [PubMed]
178. Krishnamurthy, K.; Laskowitz, D.T. Cellular and molecular mechanisms of secondary neuronal injury. In Translational Research in Traumatic Brain Injury; Laskowitz, D., Grant, G., Eds.; CRC Press/Taylor and Francis Group: Boca Raton, FL, USA, 2016.
179. Prasad, K.N.; Bondy, S.C. Common biochemical defects linkage between post-traumatic stress disorders, mild traumatic brain injury (TBI) and penetrating TBI. Brain Res. 2015, 1599, 103-114. [CrossRef] [PubMed]
180. Camacho, A.; Massieu, L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 2006, 37, 11-18. [CrossRef] [PubMed]
181. Kostandy, B.B. The role of glutamate in neuronal ischemic injury: The role of spark in fire. Neurol. Sci. 2012, 33, 223-237. [CrossRef] [PubMed]
182. Coulter, D.A.; Eid, T. Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 2012, 60, 1215-1226. [CrossRef] [PubMed]
183. Johnston, M.V. Excitotoxicity in perinatal brain injury. Brain Pathol. 2005, 15, 234-240. [CrossRef] [PubMed]
184. Zádori, D.; Veres, G.; Szalárdy, L.; Klivényi, P.; Toldi, J.; Vécsei, L. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets. J. Alzheimers Dis. 2014, 42, S177-S187. [PubMed]
185. Ong,W.Y.; Tanaka, K.; Dawe, G.S.; Ittner, L.M.; Farooqui, A.A. Slow excitotoxicity in Alzheimer's disease. J. Alzheimers Dis. 2013, 35, 643-668. [PubMed]
186. Rothstein, J.D.; Tsai, G.; Kuncl, R.W.; Clawson, L.; Cornblath, D.R.; Drachman, D.B.; Pestronk, A.; Stauch, B.L.; Coyle, J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 1990, 28, 18-25. [CrossRef] [PubMed]
187. Rothstein, J.D. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 1995, 3, 348-59. [PubMed]
188. King, A.E.; Woodhouse, A.; Kirkcaldie, M.T.; Vickers, J.C. Excitotoxicity in ALS: Overstimulation, or overreaction? Exp. Neurol. 2016, 275, 162-171. [CrossRef] [PubMed]
189. Blasco, H.; Mavel, S.; Corcia, P.; Gordon, P.H. The glutamate hypothesis in ALS: Pathophysiology and drug development. Curr. Med. Chem. 2014, 21, 3551-3575. [CrossRef] [PubMed]
190. André, V.M.; Cepeda, C.; Levine, M.S. Dopamine and glutamate in Huntington's disease: A balancing act. CNS Neurosci. Ther. 2010, 16, 163-178. [CrossRef] [PubMed]
191. Meredith, G.E.; Totterdell, S.; Beales, M.; Meshul, C.K. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp. Neurol. 2009, 219, 334-340. [CrossRef] [PubMed]
192. Ambrosi, G.; Cerri, S.; Blandini, F. A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. J. Neural Transm. 2014, 121, 849-859. [CrossRef] [PubMed]
193. Hoque, A.; Hossain, M.I.; Ameen, S.S.; Ang, C.S.; Williamson, N.; Ng, D.C.; Chueh, A.; Roulston, C.; Cheng, H.C. A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacol. Ther. 2016. in press. [CrossRef] [PubMed]
194. Fontana, A.C. Current approaches to enhance glutamate transporter function and expression. J. Neurochem. 2015, 134, 982-1007. [CrossRef] [PubMed]
195. Takahashi, K.; Foster, J.B.; Lin, C.L. Glutamate transporter EAAT2: Regulation, function, and potential as a therapeutic target for neurological and psychiatric disease. Cell. Mol. Life Sci. 2015, 72, 3489-3506. [CrossRef] [PubMed]
196. Soni, N.; Reddy, B.V.; Kumar, P. GLT-1 transporter: An effective pharmacological target for various neurological disorders. Pharmacol. Biochem. Behav. 2014, 127, 70-81. [CrossRef] [PubMed]
197. Khanna, S.; Briggs, Z.; Rink, C. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke. Antioxid. Redox Signal. 2015, 22, 175-186. [CrossRef] [PubMed]
198. Pérez-Mato, M.; Ramos-Cabrer, P.; Sobrino, T.; Blanco, M.; Ruban, A.; Mirelman, D.; Menendez, P.; Castillo, J.; Campos, F. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia. Cell Death Dis. 2014. [CrossRef] [PubMed]
199. Ghoddoussi, F.; Galloway, M.P.; Jambekar, A.; Bame, M.; Needleman, R.; Brusilow, W.S. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J. Neurol. Sci. 2010, 290, 41-47. [CrossRef] [PubMed]
200. Bame, M.; Pentiak, P.A.; Needleman, R.; Brusilow, W.S. Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS. Gend. Med. 2012, 9, 524-535. [CrossRef] [PubMed]